Growth Metrics

Pacific Biosciences Of California (PACB) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.19%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 64.73%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 30.89%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 60.12%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 29.56%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn 54.53%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 54.53%
Dec 31, 2025 21.79%
Sep 30, 2025 20.97%
Jun 30, 2025 16.26%
Mar 31, 2025 -73.56%
Dec 31, 2024 26.71%
Jun 30, 2024 -61.48%
Mar 31, 2024 -30.10%
Dec 31, 2023 -45.72%
Sep 30, 2023 -41.29%
Jun 30, 2023 -43.72%
Mar 31, 2023 -38.71%
Dec 31, 2022 -65.56%
Sep 30, 2022 -38.81%
Jun 30, 2022 -41.83%
Mar 31, 2022 -38.38%
Dec 31, 2021 -30.42%
Jun 30, 2021 -22.59%
Mar 31, 2021 -13.11%
Dec 31, 2020 76.97%
Sep 30, 2020 -2.21%
Jun 30, 2020 2.28%
Mar 31, 2020 -10.96%
Dec 31, 2019 0.21%
Sep 30, 2019 -17.91%
Jun 30, 2019 -9.88%
Mar 31, 2019 -16.72%
Dec 31, 2018 -157.28%
Sep 30, 2018 -149.33%
Jun 30, 2018 -22.77%
Mar 31, 2018 -7.00%
Dec 31, 2017 -4.35%
Sep 30, 2017 -34.48%
Jun 30, 2017 -9.88%
Mar 31, 2017 -8.44%
Dec 31, 2016 -1.88%
Sep 30, 2016 5.22%
Jun 30, 2016 3.00%
Mar 31, 2016 2.75%
Dec 31, 2015 56.15%
Sep 30, 2015 27.71%
Jun 30, 2015 18.89%
Mar 31, 2015 10.04%
Dec 31, 2014 6.38%
Sep 30, 2014 32.31%
Jun 30, 2014 5.70%
Mar 31, 2014 18.50%
Dec 31, 2013 21.50%
Sep 30, 2013 20.28%
Jun 30, 2013 14.16%